Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Batch Number Generation and Control – V 2.0

Posted on By

API Manufacturing: SOP for Batch Number Generation and Control – V 2.0

Standard Operating Procedure for Batch Number Generation and Control in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/184/2025
Supersedes SOP/API/184/2022
Page No. Page 1 of 14
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define the procedure for the generation, assignment, and control of batch numbers for Active Pharmaceutical Ingredients (APIs), intermediates, and other GMP-manufactured materials to ensure traceability, proper documentation, and compliance with regulatory requirements.

2. Scope

This SOP applies to all GMP batches of APIs, intermediates, and pilot-scale products manufactured at the facility. It includes generation logic, recording, issuance, usage,

and tracking of batch numbers across all manufacturing and quality-related documents.

3. Responsibilities

  • QA Department: Responsible for generation, approval, and control of batch numbers. Maintains master logbook.
  • Production Department: Requests batch numbers and ensures proper documentation in all batch-related records.
  • QC Department: Verifies batch number in samples, CoA, and analytical records.
See also  API Manufacturing: SOP for Weighing of Raw Materials Under LAF - V 2.0

4. Accountability

The Head of QA is accountable for ensuring that the batch number generation and control system is implemented consistently and that batch traceability is maintained.

5. Procedure

5.1 Batch Number Format

  1. Batch numbers shall be generated using the following format: [Product Code]/[YYMM]/[Serial Number]
    Example: API01/2504/001 where:
    • API01 = Unique Product Code assigned by QA
    • 2504 = Year (2025) and Month (April)
    • 001 = Serial number starting from 001 for each month

5.2 Batch Number Request and Approval

  1. Production shall request batch numbers using the Batch Number Request Form (Annexure-1).
  2. QA shall verify:
    • Product name and code
    • Manufacturing schedule
    • Material planning confirmation
  3. QA shall assign batch numbers and record details in the Batch Number Issuance Register (Annexure-2).

5.3 Control of Batch Numbers

  1. Each batch number must be:
    • Unique and non-repetitive
    • Pre-approved before use
    • Linked to a specific manufacturing BMR
  2. No batch number shall be used without QA issuance and authorization.
  3. In case of batch cancellation, the number shall be marked as “Cancelled” with reason.
See also  API Manufacturing: SOP for Line Clearance Before Start of Manufacturing - V 2.0

5.4 Batch Number Usage and Tracking

  1. Batch number must appear on:
    • Batch Manufacturing Record (BMR)
    • In-process sampling labels
    • QC test reports
    • Packing and labeling materials
    • Release documents and CoA
  2. Each step must ensure that the batch number is consistent across all associated documentation.

5.5 Electronic Batch Number Systems (if applicable)

  1. If batch numbers are managed in an ERP or LIMS:
    • Only authorized QA personnel shall have access rights for generation
    • System audit trail must be enabled
    • Electronic batch numbers must sync with physical BMR

5.6 Batch Number Review and Audit

  1. QA shall conduct quarterly audits of batch number issuance and traceability.
  2. Verify against production and release records.
  3. Any discrepancy must be investigated using the Batch Number Discrepancy Form (Annexure-3).

6. Abbreviations

  • API: Active Pharmaceutical Ingredient
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • QC: Quality Control
  • LIMS: Laboratory Information Management System
  • ERP: Enterprise Resource Planning

7. Documents

  1. Batch Number Request Form (Annexure-1)
  2. Batch Number Issuance Register (Annexure-2)
  3. Batch Number Discrepancy Form (Annexure-3)
See also  API Manufacturing: SOP for Maintenance of Drying and Milling Logs - V 2.0

8. References

  • ICH Q7 – GMP for APIs
  • 21 CFR Part 211.105 – Equipment identification
  • EU GMP Part II – Section 5 and 6

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Number Request Form

Product Name Product Code Requested By Date
API-X API01 Rajesh Kumar 10/04/2025

Annexure-2: Batch Number Issuance Register

Batch No. Product Code Issued By Issue Date Status
API01/2504/001 API01 Sunita Reddy 11/04/2025 Active

Annexure-3: Batch Number Discrepancy Form

Batch No. Discrepancy Description Investigation Summary Action Taken
API01/2504/004 Mismatch in CoA and BMR Typographical error Corrected and retrained staff

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Version New SOP QA Head
14/04/2025 2.0 Included ERP/LIMS usage System integration QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Ensuring Sample Integrity Before Analysis – V 2.0
Next Post: Gel Manufacturing: SOP for Recording and Reporting In-Process Control Data – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version